Anne Cooper

697 total citations
7 papers, 517 citations indexed

About

Anne Cooper is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Anne Cooper has authored 7 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Anne Cooper's work include Cardiovascular Function and Risk Factors (2 papers), Heart Failure Treatment and Management (2 papers) and Hormonal and reproductive studies (1 paper). Anne Cooper is often cited by papers focused on Cardiovascular Function and Risk Factors (2 papers), Heart Failure Treatment and Management (2 papers) and Hormonal and reproductive studies (1 paper). Anne Cooper collaborates with scholars based in United Kingdom, United States and France. Anne Cooper's co-authors include Anthony M. Heagerty, Niels K. Thybo, Michael J. Mulvany, Christian Aalkjær, Julian Wright, Robert N. Foley, Philip A. Kalra, Paul R. Kalra, Gavin A. Lewis and Susanna Dodd and has published in prestigious journals such as Nature Medicine, Hypertension and Journal of the American Society of Nephrology.

In The Last Decade

Anne Cooper

7 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Cooper United Kingdom	6	384	129	112	93	69	7	517
Karin Tyralla Germany	8	236 0.6×	78 0.6×	58 0.5×	57 0.6×	50 0.7×	8	552
Liliana Legedz France	10	268 0.7×	83 0.6×	89 0.8×	75 0.8×	31 0.4×	19	405
Clarito Dimayuga United States	6	334 0.9×	69 0.5×	89 0.8×	53 0.6×	86 1.2×	7	475
Kazuaki Uchino Japan	17	467 1.2×	78 0.6×	167 1.5×	112 1.2×	35 0.5×	59	703
Aimin Dang China	11	173 0.5×	110 0.9×	94 0.8×	38 0.4×	44 0.6×	31	383
Reiko Doi Japan	9	283 0.7×	39 0.3×	67 0.6×	61 0.7×	55 0.8×	21	421
Litong Qi China	12	232 0.6×	69 0.5×	91 0.8×	45 0.5×	27 0.4×	45	430
Toshiyuki Niki Japan	15	334 0.9×	72 0.6×	149 1.3×	59 0.6×	41 0.6×	28	588
Hirofumi Noike Japan	10	445 1.2×	106 0.8×	221 2.0×	155 1.7×	40 0.6×	34	602
Akira Mende Japan	11	310 0.8×	106 0.8×	196 1.8×	79 0.8×	63 0.9×	14	503

Countries citing papers authored by Anne Cooper

Since Specialization

Citations

This map shows the geographic impact of Anne Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Cooper more than expected).

Fields of papers citing papers by Anne Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Cooper. The network helps show where Anne Cooper may publish in the future.

Co-authorship network of co-authors of Anne Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Cooper. A scholar is included among the top collaborators of Anne Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Cooper. Anne Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Forde, Rita, Lisa King, Anne Cooper, Kirsty Winkley, & Vivien Coates. (2024). Type 1 diabetes and menopause, what women would like to know: a public and patient involvement exercise. 17. 1 indexed citations

2.

Lewis, Gavin A., Susanna Dodd, Emma Bedson, et al.. (2021). Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial. Nature Medicine. 27(8). 1477–1482. 126 indexed citations

3.

Lewis, Gavin A., Erik B. Schelbert, Josephine H. Naish, et al.. (2019). Pirfenidone in Heart Failure with Preserved Ejection Fraction—Rationale and Design of the PIROUETTE Trial. Cardiovascular Drugs and Therapy. 33(4). 461–470. 45 indexed citations

4.

Wright, Julian, et al.. (2005). Left Ventricular Morphology and Function in Patients with Atherosclerotic Renovascular Disease. Journal of the American Society of Nephrology. 16(9). 2746–2753. 66 indexed citations

5.

Cooper, Anne & Anthony M. Heagerty. (1998). Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia. American Journal of Physiology-Heart and Circulatory Physiology. 275(4). H1482–H1488. 23 indexed citations

6.

Cooper, Anne & Anthony M. Heagerty. (1997). Blood Pressure Parameters as Determinants of Small Artery Structure in Human Essential Hypertension. Clinical Science. 92(6). 551–557. 9 indexed citations

7.

Thybo, Niels K., et al.. (1995). Effect of Antihypertensive Treatment on Small Arteries of Patients With Previously Untreated Essential Hypertension. Hypertension. 25(4). 474–481. 247 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact